This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.
The tumoral molecular landscape of long-term survivors with isocitrate dehydrogenase wildtype glioblastoma: Lessons from ETERNITY (EORTC 1419). Efficacy and safety outcomes of depatuxizumab mafodotin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results